Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases

Journal of Immunotherapy

Volumn 24, Issue 6, 2001, Pages 447-458

  Mocellin, S ^a   Fetsch, P ^a   Abati, A ^a   Phan, G Q ^a   Wang, E ^a   Provenzano, M ^a   Stroncek, D ^a   Rosenberg, S A ^a   Marincola, F M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gp100; HLA Laser scanning cytometer; MART 1; Melanoma

Indexed keywords

GLYCOPROTEIN GP 100; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; MELAN A;

ANTIGEN EXPRESSION; ARTICLE; ASPIRATION BIOPSY; CELL SUBPOPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MELANOMA; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; IMAGE CYTOMETRY; LASERS; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035192569     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200111000-00002     Document Type: Article

References (36)

1. Escape of human solid tumors from T cell recognition: Molecular mechanisms and functional significance
2. Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T-lymphocytes
3. A natural history of melanoma: Serial gene expression analysis
4. Short-term kinetics of tumor antigen expression in response to vaccination
5. Quantitative correlation between HLA Class I allele expression and recognition of melanoma cells by antigen specific cytotoxic T lymphocytes
6. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model
7. Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination
8. Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data
9. Laser scanning cytometry: A new instrumentation with many applications
10. Slide-based laser scanning cytometry
11. Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry
12. Simplified immunophenotypic analysis by laser scanning cytometry
13. Five-color immunophenotyping plus DNA content analysis by laser scanning cytometry
14. Analysis of apoptosis in solid tumors by laser scanning cytometry
15. Analysis of apoptosis by laser scanning cytometry
16. Laser scanning cytometry quantification of estrogen receptors in breast cancer
17. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: Evidencefor in vivo priming by tumor cells
18. Genetic polymorphism within HLA-A*02: Significant allelic variation revealed in different populations
19. Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma
20. Production of recombinant MART-1 proteins and specific anti-MART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1
21. Benign and malignant cells in effusions: Diagnostic value of image DNA cytometry in comparison to cytological analysis
22. Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions
23. Aneuploidy as a marker of minimal residual disease in leukemia
24. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors
25. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumors of borderline malignancy
26. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melano-cytic lesions of the skin using video imaging
27. Multiple genetic alterations cause a frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer
28. Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry
29. Analysis of the DNA content in the progression of recurrent and metastatic melanomas
30. DNA ploidy and S-phase fraction in primary melanomas and their regional metastases
31. Sequential DNA flow cytometry in metastatic malignant malanoma
32. Prognostic significance of newly defined ploidy related parameters in melanoma
33. Prognostic significance of DNA cytometry in comparison with histologic measurements in malignant melanomas
34. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer
35. Analysis of expression of the melanoma associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
36. Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma